Published in

Taylor and Francis Group, Expert Opinion on Drug Metabolism and Toxicology, 2(15), p. 133-149, 2019

DOI: 10.1080/17425255.2019.1563071

Links

Tools

Export citation

Search in Google Scholar

Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens

Journal article published in 2019 by Ilias Karaiskos ORCID, Irene Galani ORCID, Maria Souli ORCID, Helen Giamarellou ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO